The DOI matches its Crossref record; the references it cites are not checked yet.
A Review on Theranostics: An Approach to Targeted Diagnosis and Therapy
Open accessAbstract
Emerging as a targeted, safe, and efficient pharmacotherapy is the approach of theranostics, which focuses on patient centered care. It is a combination of diagnosis and therapeutics. Theranostics is a new field of medicine which combines specific targeted therapy based on specific targeted diagnostic tests. With a key focus on patient centered care, theranostics provides a transition from conventional medicine to a contemporary personalized and precision medicine approach. The theranostics paradigm involves using nanoscience to unite diagnostic and therapeutic applications to form a single agent, allowing for diagnosis, drug delivery and treatment response monitoring. The theranostics medicine can achieve systemic circulation, evade host defenses and deliver the drug and diagnostic agents at the targeted site to diagnose and treat the disease at cellular and molecular level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cases demonstrate the synergistic effects of combining radiopharmaceutical treatments with systemic therapies, surgical interventions, or external beam radiation, expanding the spectrum of therapeutic options for patients with bone metastases.”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [108]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 9 · Cited by 53
Research works printed but not linked: 5
- Thangadurai M, Nalliapan G, Janardhanam DS, et al. Theranostics an Emerging Paradigm-a Review. IOSR Journal of Dental and Medical Sciences. 2018; 17(11): 01-07.
- Madaswamy S. Muthu, David Tai Leong, Lin Mei, Si-Shen Feng. Nanotheranostics ˗ Application and Further Development ofNanomedicine Strategies for Advanced Theranostics, Theranostics 2014; 4(6):660-677.
- Warland S, Hesse M, Renauld L, Jumar F. The impact of image reconstruction bias on PET/CT 90 Y dosimetry after radioemobilisation. J Nucl Med, 2015; 56(3):494-495.
- Nimita L. Pharmacogenomics, Theranostics and Personalised medicine-The complexities of clinical trials: challenges in the developing world. Appl Transl Genomics, 2013; 2:17-21.
- Bhattarai N, Bhattarai SR. Therapeutic nanoparticles: A recent breakthrough in Nanotechnology. J Nanomed Nanotechnol. 2012; 3:e114.
Metadata
- Authors
- Shrivastava, S., Jain, S., Kumar, D., Soni, S. L., & Sharma, M.
- Venue
- Asian Journal of Pharmaceutical Research and Development
- Publisher
- Society of Pharmaceutical Tecnocrats
- Published
- 2019-04-14
- Volume
- 7
- Issue
- 2
- Pages
- 63-69
- ISSN
- 2320-4850 (ISSN-L)
- OpenAlex
- W2954555740
- Cited by
- 53
- References
- 9
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 2
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Asian Journal of Pharmaceutical Research and Development (publishedVersion, cc-by-nc)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- theranostics, targeted therapy, personalized medicine, precision medicine, nanomedicine, drug delivery, treatment response monitoring, patient-centered care, molecular imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review on Theranostics: An Approach to Targeted Diagnosis and Therapy. https://app.cochat.ai/papers/10.22270/ajprd.v7i2.463
- The paper
- Shrivastava, S., Jain, S., Kumar, D., Soni, S. L., & Sharma, M. (2019). A Review on Theranostics: An Approach to Targeted Diagnosis and Therapy. Asian Journal of Pharmaceutical Research and Development. https://doi.org/10.22270/ajprd.v7i2.463
